Take a look back at our most popular news from October 2022.
Did you miss the top stories on Drug Topics® this month? Catch up on these noteworthy stories today.
10. Examining Factors That Impact Antibiotic Prescribing in Urgent Care
Determining the characteristics that impact antibiotic prescribing behavior is important for addressing health inequity.
9. NCPA Urges Department of Defense to Address Pharmacy Access Restrictions for Tricare Beneficiaries
The new restrictions include both independent and chain pharmacies.
8. Increased HPV Knowledge Could Lead to Increased Vaccination Rates
Improving vaccination rates for the most common STI in the United States could be as simple as increasing knowledge about HPV.
7. Industry Trends: What to Watch For
From biosimilars to artificial intelligence, these are the trends poised to take community pharmacy by storm.
6. Stelara Study Shows Efficacy for Ulcerative Colitis
Clinical trial results reported at United European Gastroenterology Week 2022 highlight Stelara's effectiveness.
5. Community Health Workers Drive Value in Pharmacies
In an age where pharmacies are expected to do more than provide medication, community health workers add necessary value.
4. Robotic Capsule Can Help Patients Digest Vancomycin, Insulin
Technlogy could greatly improve drug absorption.
3. Preparing to Counsel Patients on OTC Hearing Aids
OTC hearing aids will soon be available, but this access also comes with questions about counseling and ensuring safety.
2. Motivate, Incentivize Your Team After the “Great Resignation”
It’s more important than ever to keep your team motivated and incentivized.
1. UAMS Wins NCPA 2022 Good Neighbor Pharmacy Pruitt-Schutte Student Business Plan Competition
The winner was announced during the first General Session of the 2022 NCPA Annual Convention.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.